Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Phase 2 Study of aTezolizumab, bevAcizumab, and Cobinetin... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Phase 2 Study of aTezolizumab, bevAcizumab, and Cobinetinib (TACo) in patients (pts) with PD1 refractory metastatic brain metastases (MBM)
0
Authors
Elizabeth Burton
15 more
Elizabeth Burton
•
Isabella Glitza
13 more
•
Hussein Tawbi
Published
January 1, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
EJC Skin Cancer
Topics
Medicine
Materials Science
Cancer Oncology
Internal Medicine
Pulmonary And Respiratory Medicine
Show all topics
DOI
10.1016/j.ejcskn.2024.100160
License
CC-BY-NC-ND
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
EJC Skin Cancer
Topics
Medicine
Materials Science
Cancer Oncology
Internal Medicine
Pulmonary And Respiratory Medicine
Show all topics
DOI
10.1016/j.ejcskn.2024.100160
License
CC-BY-NC-ND
